Literature DB >> 32697762

The biological and diagnostic roles of MicroRNAs in meningiomas.

Lei Wang1, Shengpan Chen2,3, Yan Liu4, Hongqi Zhang2,3, Nianjun Ren1, Ruoyu Ma5, Zhengwen He1.   

Abstract

MicroRNAs (miRNAs) refer to a class of small endogenous non-coding RNAs that regulate gene expression at the post-transcriptional level. Emerging studies have shown that miRNAs play critical roles in tumorigenesis and cancer progression. However, roles and mechanisms of miRNA dysregulation in the pathogenesis of meningioma are not fully understood. Here, we first reviewed existing research of aberrantly expressed miRNAs identified by high throughput microarray profiling in meningioma. We also explored the potential of miRNA as biomarkers and therapeutic targets for novel treatment paradigms of meningiomas. In addition, we summarized recent researches that focused on the possible mechanisms involved in miRNA-mediate meningioma occurrence and progression. This review provides an overview of miRNA deregulation in meningioma and indicates the potential of miRNAs to be used as biomarkers or novel therapeutic targets.

Entities:  

Keywords:  biological roles; biomarker; diagnosis; meningioma; microRNAs

Year:  2020        PMID: 32697762     DOI: 10.1515/revneuro-2020-0023

Source DB:  PubMed          Journal:  Rev Neurosci        ISSN: 0334-1763            Impact factor:   4.353


  3 in total

1.  miR-497 and 219 in blood aid meningioma classification.

Authors:  Ahmed Abdelrahman; Caterina Negroni; Felix Sahm; Claire L Adams; Tadeja Urbanic-Purkart; Michael Khalil; Raffaellla Vergura; Cristina Morelli; Clemens Oliver Hanemann
Journal:  J Neurooncol       Date:  2022-09-08       Impact factor: 4.506

2.  miR-127-5p Targets JAM3 to Regulate Ferroptosis, Proliferation, and Metastasis in Malignant Meningioma Cells.

Authors:  Jing Zhang; Zang Liu; Yipeng Dong
Journal:  Dis Markers       Date:  2022-07-02       Impact factor: 3.464

3.  The role of gut microbiota in patients with benign and malignant brain tumors: a pilot study.

Authors:  Haixiao Jiang; Wei Zeng; Xiaoli Zhang; Yunlong Pei; Hengzhu Zhang; Yuping Li
Journal:  Bioengineered       Date:  2022-03       Impact factor: 6.832

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.